We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

95 hedge funds and large institutions have $109M invested in Enzo Biochem, Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

25% more capital invested

Capital invested by funds: $87.8M → $109M (+$21.7M)

12% more funds holding

Funds holding: 85 → 95 (+10)

12% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
29
Reduced
26
Closed
6
Calls
$174K
Puts
–
Net Calls
+$174K
Net Calls Change
+$157K

Top Buyers

Rank Fund Capital Flow
1
HFA
Harbert Fund Advisors
Alabama
+$7.52M
2
AI
Ariel Investments
Illinois
+$1.14M
3
N
Nuveen
North Carolina
+$767K
4
EI
EAM Investors
California
+$630K
5
FM
Fondren Management
Texas
+$620K

Top Sellers

Rank Fund Capital Flow
1
EGA
Evermore Global Advisors
New Jersey
-$3.52M
2
RAM
Roumell Asset Management
Maryland
-$2.34M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.48M
4
BlackRock
BlackRock
New York
-$802K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$478K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$13K +$13.2K +3,739 New
AIP
77
Ameritas Investment Partners
Nebraska
$10K – – –
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$9K +$6.63K +1,881 +250%
PHK
79
Point72 Hong Kong
Hong Kong
$9K +$8.92K +2,531 New
AG
80
Advisor Group
Arizona
$6K – – –
QT
81
Quantamental Technologies
New York
$6K – – –
MAM
82
Meeder Asset Management
Ohio
$6K +$6.2K +1,760 New
PAM
83
Panagora Asset Management
Massachusetts
$4K -$19K -5,381 -80%
Simplex Trading
84
Simplex Trading
Illinois
$4K +$4.84K +1,374 New
AG
85
Aperio Group
California
$3K +$2.92K +828 New
ASN
86
Advisory Services Network
Georgia
$2K – – –
Federated Hermes
87
Federated Hermes
Pennsylvania
$1K -$28 -8 -3%
BEI
88
Benjamin Edwards Inc
Missouri
$1K – – –
YWP
89
YorkBridge Wealth Partners
New York
$1K – – –
PCP
90
Proficio Capital Partners
Massachusetts
$1K +$958 +272 New
LTFS
91
Ladenburg Thalmann Financial Services
Florida
$1K +$1.48K +419 +4,190%
Assenagon Asset Management
92
Assenagon Asset Management
Luxembourg
– -$211K -77,313 Closed
SEI Investments
93
SEI Investments
Pennsylvania
– -$66K -24,225 Closed
MAA
94
Mraz Amerine & Associates
California
– -$49K -18,100 Closed
JT
95
Jump Trading
Illinois
– -$44K -16,017 Closed
MSL
96
Mackay Shields LLC
New York
– -$38K -13,900 Closed
1 2 3
4

ENZ Hedge Fund Activity: Q2 2019 in Review

95 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2019, worth a combined $109M — up 25% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ENZ positions and 6 closed out — a net gain of 12 holders — while 29 added to existing stakes and 26 trimmed.

The largest buyer was Harbert Fund Advisors, adding an estimated $7.52M. The largest seller was Evermore Global Advisors, cutting an estimated $3.52M.

  • 95 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2019, up from 85 in Q1 2019.
  • Funds reported $109M of Enzo Biochem, Inc. stock for Q2 2019, up 25% quarter-over-quarter.
  • 18 funds opened new Enzo Biochem, Inc. positions in Q2 2019 and 6 closed out, a net change of +12 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2019 was Harbert Fund Advisors, an estimated $7.52M added.
  • The largest Enzo Biochem, Inc. seller in Q2 2019 was Evermore Global Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2019.